BiotechTube
Home/Pipeline/OmiCrisp

OmiCrisp

SARS‑CoV‑2 variant‑specific detection

Market-readyActive

Key Facts

Indication
SARS‑CoV‑2 variant‑specific detection
Phase
Market-ready
Status
Active
Company
CrisprBits

About CrisprBits

CRISPR‑based platform delivering affordable diagnostics and gene‑editing solutions for diverse industries.

View full company profile

Therapeutic Areas

Genetic disordersInfectious diseases